Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P0C0E4: Variant p.Asp59Gly

Ras-related protein Rab-40A-like
Gene: RAB40AL
Feedback?
Variant information Variant position: help 59 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Glycine (G) at position 59 (D59G, p.Asp59Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help Renders the protein unstable and disrupts its cytoplasmic localization. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 59 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 278 The length of the canonical sequence.
Location on the sequence: help AESPYSHLGGIDYKTTTILL D GQRVKLKLWDTSGQGRFCTI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 278 Ras-related protein Rab-40A-like



Literature citations
Disruption of RAB40AL function leads to Martin--Probst syndrome, a rare X-linked multisystem neurodevelopmental human disorder.
Bedoyan J.K.; Schaibley V.M.; Peng W.; Bai Y.; Mondal K.; Shetty A.C.; Durham M.; Micucci J.A.; Dhiraaj A.; Skidmore J.M.; Kaplan J.B.; Skinner C.; Schwartz C.E.; Antonellis A.; Zwick M.E.; Cavalcoli J.D.; Li J.Z.; Martin D.M.;
J. Med. Genet. 49:332-340(2012)
Cited for: SUBCELLULAR LOCATION; TISSUE SPECIFICITY; VARIANT GLY-59; CHARACTERIZATION OF VARIANT GLY-59; Evidence against RAB40AL being the locus for Martin-Probst X-linked deafness-intellectual disability syndrome.
Oldak M.; Sciezynska A.; Mlynarski W.; Borowiec M.; Ruszkowska E.; Szulborski K.; Pollak A.; Kosinska J.; Mueller-Malesinska M.; Stawinski P.; Szaflik J.P.; Ploski R.;
Hum. Mutat. 35:1171-1174(2014)
Cited for: VARIANT GLY-59; A note of caution on the diagnosis of Martin-Probst syndrome by the detection of the p.D59G mutation in the RAB40AL gene.
Oldak M.; Ruszkowska E.; Pollak A.; Sobczyk-Kopciol A.; Kowalewski C.; Piwonska A.; Drygas W.; Ploski R.;
Eur. J. Pediatr. 174:693-696(2015)
Cited for: VARIANT GLY-59; Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results.
Bianco A.M.; Faletra F.; Vozzi D.; Girardelli M.; Knowles A.; Tommasini A.; Zauli G.; Marcuzzi A.;
Mol. Med. Report. 12:6128-6132(2015)
Cited for: VARIANT GLY-59;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.